These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26504007)

  • 1. A Theoretical Model for the Hormetic Dose-response Curve for Anticancer Agents.
    Yoshimasu T; Ohashi T; Oura S; Kokawa Y; Kawago M; Hirai Y; Miyasaka M; Nishiguchi H; Kawashima S; Yata Y; Honda M; Fujimoto T; Okamura Y
    Anticancer Res; 2015 Nov; 35(11):5851-5. PubMed ID: 26504007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dose response curve of paclitaxel measured by histoculture drug response assay].
    Yoshimasu T; Oura S; Hirai I; Kokawa Y; Okamura Y; Furukawa T
    Gan To Kagaku Ryoho; 2005 Apr; 32(4):497-500. PubMed ID: 15853216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma.
    Carter CA; Chen C; Brink C; Vincent P; Maxuitenko YY; Gilbert KS; Waud WR; Zhang X
    Cancer Chemother Pharmacol; 2007 Feb; 59(2):183-95. PubMed ID: 16724239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer.
    Fahham D; Weiss ID; Abraham M; Beider K; Hanna W; Shlomai Z; Eizenberg O; Zamir G; Izhar U; Shapira OM; Peled A; Wald O
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1167-1175.e1. PubMed ID: 22925564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of chemotherapeutic effect on postoperative recurrence by in vitro anticancer drug sensitivity testing in non-small cell lung cancer patients.
    Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Imamura F; Minamikawa K; Takano T; Kobayashi H
    Lung Cancer; 2010 Jun; 68(3):472-7. PubMed ID: 19660825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of acriflavine in lung adenocarcinoma cell line A549.
    Lee CJ; Yue CH; Lin YJ; Lin YY; Kao SH; Liu JY; Chen YH
    Anticancer Res; 2014 Nov; 34(11):6467-72. PubMed ID: 25368247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel-octreotide conjugates inhibit growth of human non-small cell lung cancer cells in vitro.
    Sun ML; Wei JM; Wang XW; Li L; Wang P; Li M; Yi CH
    Exp Oncol; 2007 Sep; 29(3):186-91. PubMed ID: 18004242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormetic Effect of Berberine Attenuates the Anticancer Activity of Chemotherapeutic Agents.
    Bao J; Huang B; Zou L; Chen S; Zhang C; Zhang Y; Chen M; Wan JB; Su H; Wang Y; He C
    PLoS One; 2015; 10(9):e0139298. PubMed ID: 26421434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.
    Chan DC; Gera L; Stewart JM; Helfrich B; Zhao TL; Feng WY; Chan KK; Covey JM; Bunn PA
    Clin Cancer Res; 2002 May; 8(5):1280-7. PubMed ID: 12006549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase.
    Sirotnak FM; Zakowski MF; Miller VA; Scher HI; Kris MG
    Clin Cancer Res; 2000 Dec; 6(12):4885-92. PubMed ID: 11156248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of lobaplatin alone or in combination with antitubulin agents in non-small-cell lung cancer.
    Xie CY; Xu YP; Jin W; Lou LG
    Anticancer Drugs; 2012 Aug; 23(7):698-705. PubMed ID: 22441567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer activity of SAHA, a potent histone deacetylase inhibitor, in NCI-H460 human large-cell lung carcinoma cells in vitro and in vivo.
    Zhao Y; Yu D; Wu H; Liu H; Zhou H; Gu R; Zhang R; Zhang S; Wu G
    Int J Oncol; 2014 Feb; 44(2):451-8. PubMed ID: 24297449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
    Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X
    Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Darbufelone, a novel anti-inflammatory drug, induces growth inhibition of lung cancer cells both in vitro and in vivo.
    Ye X; Zhou W; Li Y; Sun Y; Zhang Y; Ji H; Lai Y
    Cancer Chemother Pharmacol; 2010 Jul; 66(2):277-85. PubMed ID: 20352217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2,6-Disubstituted imidazo[2,1-b][1,3,4]thiadiazoles: search for anticancer agents.
    Noolvi MN; Patel HM; Kamboj S; Kaur A; Mann V
    Eur J Med Chem; 2012 Oct; 56():56-69. PubMed ID: 22960694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
    Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly sensitive and selective anticancer effect by conjugated HA-cisplatin in non-small cell lung cancer overexpressed with CD44.
    Quan YH; Kim B; Park JH; Choi Y; Choi YH; Kim HK
    Exp Lung Res; 2014 Dec; 40(10):475-84. PubMed ID: 25299431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
    Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway.
    Ren T; Shan J; Qing Y; Qian C; Li Q; Lu G; Li M; Li C; Peng Y; Luo H; Zhang S; Zhang W; Wang D; Zhou SF
    Drug Des Devel Ther; 2014; 8():2517-29. PubMed ID: 25548514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.